Manjari Lal

发表

Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system

M. Lal, W. Weldon, D. Koelle, 2014, Human vaccines & immunotherapeutics.

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

M. Lal, J. McLellan, A. García-Sastre, 2022, Vaccine.

DC Magnetic Field Induced Magnetocytolysis of Cancer Cells Targeted by LH-RH Magnetic Nanoparticles in vitro

Earl J. Bergey, Linda J. Krebs, Charles Liebow, 2002 .

Preformulation studies with the Escherichia coli double mutant heat-labile toxin adjuvant for use in an oral vaccine

M. Lal, Dexiang Chen, Marcus R. Estrada, 2017, Journal of immunological methods.

Preparation of ultrafine high density gamma ferric oxide using aerosol OT microemulsions and its characterization

A. Maitra, M. Lal, P. Ayyub, 1995 .

Photogeneration, charge transport, and photoconductivity of a novel PVK/CdS-nanocrystal polymer composite

Paras N. Prasad, Christopher S. Friend, Manjari Lal, 1999 .

Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast-Dissolving Tablet Formulation

Changcheng Zhu, Manjari Lal, 2022, Pharmaceutics.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

S. Lamola, M. Lal, P. Pitisuttithum, 2022, eClinicalMedicine.

Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo

W. Heneine, M. Peet, M. Lal, 2018, Nature Communications.

Characterization of a thermostable hepatitis B vaccine formulation.

M. Lal, J. Ježek, Dexiang Chen, 2009, Vaccine.

Preparation and characterization of ultrafine TiO_2 particles in reverse micelles by hydrolysis of titanium di-ethylhexyl sulfosuccinate

A. Maitra, M. Lal, P. Ayyub, 1998 .

Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018® adjuvant

Changcheng Zhu, Manjari Lal, Anan Bzami, 2024, Human vaccines & immunotherapeutics.

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

S. Lamola, M. Lal, P. Pitisuttithum, 2021, medRxiv.

Development of a Vaginal Fast-Dissolving Insert Combining Griffithsin and Carrageenan for Potential Use Against Sexually Transmitted Infections.

M. Lal, O. Mizenina, Shweta R. Ugaonkar, 2018, Journal of pharmaceutical sciences.

Multifunctional polymers as multi‐role materials for photonics

J. Bhawalkar, P. Prasad, N. Kumar, 1997 .

Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method.

J. Hickling, D. Kristensen, S. Kapre, 2010, Vaccine.

Preparing an Adjuvanted Thermoresponsive Gel Formulation for Sublingual Vaccination.

M. Lal, J. White, Changcheng Zhu, 2017, Methods in molecular biology.

Observation of the Photorefractive Effect in a Hybrid Organic-inorganic Nanocomposite

P. Prasad, M. Lal, J. Winiarz, 1999 .

Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.

M. Lal, Dexiang Chen, D. Kristensen, 2013, Vaccine.

The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation

M. Lal, D. Pittman, Manshun Lai, 2018, AIDS research and treatment.